VRTX compared with BA: revenue, margins and what each company keeps, and the suppliers and customers both name

VRTXVertex Pharmaceuticals Inc

Mkt capRevenueRevenue

BABoeing Co

Mkt capRevenueRevenue

Compare

VRTXVertex Pharmaceuticals Inc

BABoeing Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±5.2%▲+1.70%×0.33

Q1 FY26±5.4%▼−1.28%×0.24

Feb 13 '26±6.0%▲+5.69%×0.95

Q3 FY25±6.0%▼−1.02%×0.17

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±4.4%▼−10.69%×2.43

Q2 FY26±4.5%▲+4.76%×1.07

= impliedVRTX realized, solidBA realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±4.0%

▲+5.53%

×1.38

Q4 FY25±4.1%▼−1.56%×0.39

VRTXVertex Pharmaceuticals Inc

549.69▼−0.63%· post 530.56

Mkt cap$140.2BRevenue$3.3BQ2 FY26Revenue$12.0BFY25

BABoeing Co

175.35▼−0.03%· post 173.37

After hoursNov 3 '26

Mkt cap$139.0BRevenue$24.2BQ3 FY26Revenue$89.5BFY25

Compare

After hoursNov 3 '26

VRTXVertex Pharmaceuticals Inc

BABoeing Co

549.69▼−0.63%post 530.56

Price

175.35▼−0.03%post 173.37

$140.2B

Mkt cap

$139.0B

Q2 FY26$3.3B

Revenue

$24.2BQ3 FY26

FY25$12.0B

Revenue

$89.5BFY25

VRTX549.69▼−0.63%vsBA175.35▼−0.03%After hoursNov 3 '26